Jelmyto kit - antineoplastic antibiotics
Ended Awarded Last action
- Contract number
- 36C26025F0230
- Awardee
-
Urogen Pharma Inc. UEI L3U3BFJL3Z81
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $187,484
Award facts
- Contract value 100% obligated
- $187,484.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43017, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$17,044 | |
| Funding Only Action | $85,220 | |
| Funding Only Action | $17,044 | |
| Original award | $102,264 |
About this award
Urogen Pharma Inc. was awarded a delivery order valued at $187,484.22 on April 24, 2025, by Veterans Integrated Service Network 20 to supply JELMYTO Kit (mitomycin), an antineoplastic antibiotic indicated for treating low-grade upper tract urothelial cancer. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, will be performed in Dublin, Ohio and represents a non-set-aside procurement conducted under full and open competition. The award leverages the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle and reflects the Department of Veterans Affairs' continued procurement of specialized oncological treatments through Urogen Pharma Inc., a Princeton, New Jersey-based pharmaceutical company specializing in innovative cancer therapeutics for the VA healthcare system.
This delivery order is issued under a larger single-award Blanket Purchase Agreement valued at $2.5 million, established on March 1, 2021, and extending through February 28, 2026, which was awarded by the VA's National Acquisition Center. The BPA framework streamlines procurement mechanisms across multiple Veterans Integrated Service Networks, enabling efficient ordering of JELMYTO products without requiring individual competitions for each action. This delivery order marks an expansion of Urogen Pharma Inc.'s service to new veteran beneficiaries within VISN 20 and continues the company's established role as a key supplier of specialized cancer pharmaceuticals to the VA system, with prior delivery orders issued across multiple regional networks since June 2023.
Quick answers
Who was awarded contract 36C26025F0230?
36C26025F0230 was awarded to Urogen Pharma Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on April 24, 2025.
How much is contract 36C26025F0230 worth?
The government has obligated $187,484 on 36C26025F0230.
Is contract 36C26025F0230 an order under another contract?
Yes. 36C26025F0230 is a delivery order under 36F79721D0068, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0230 competed?
The extent of competition for 36C26025F0230 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award